Myelodysplastic neoplasm with increased blasts type 2

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.

"Myelodysplastic neoplasm with increased blasts type 2" OR "MDS-IB2" OR "RAEB-2" OR "Refractory anemia with excess blasts type 2" OR "MDS-EB-2" OR "RAEB-II" OR "myelodysplastic syndrome with Excess blasts-2"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Myelodysplastic neoplasm with increased blasts type 2" OR "MDS-IB2" OR "RAEB-2" OR "Refractory anemia with excess blasts type 2" OR "MDS-EB-2" OR "RAEB-II" OR "myelodysplastic syndrome with Excess blasts-2" OR "myelodysplastic syndrome with excess blasts" OR "myelodysplastic syndrome" OR "hematopoietic and lymphoid cell neoplasm"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 1238 interventional · 141 observational · 5 expanded access. Only interventional studies enter the trial headline.

Cross-references (from Mondo): UMLS:C4704767 NCIT:C7168

Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion

Run this search on ClinicalTrials.gov

Confidence reasoning

• Preferred label is multi-word and distinctive
• No synonyms dropped by stoplist
• No label/synonym collisions with other diseases in this corpus
• Publication count (1433) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity